Licensed vaccine
FluLaval
FDA-licensed vaccine · ID Biomedical Corporation of Quebec · STN 125163
Key facts
| Trade name | FluLaval |
|---|---|
| Proper name | Influenza Virus Vaccine (Trivalent, Types A and B) |
| Manufacturer | ID Biomedical Corporation of Quebec |
| Submission tracking number (STN) | 125163 |
| FDA product areas | Biologics, Vaccines |
| Recent FDA documents | July 1, 2024 Approval Letter - FLULAVAL, February 6, 2020 Approval Letter - FLULAVAL, Clinical Review - FluLaval and FluLaval Quadrivalent, Statistical Review Assay - FluLaval and FluLaval Quadrivalent, Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent, Package Insert - FLULAVAL, Supporting Documents older than three years - FluLaval |
| FDA page updated | Jul 1, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: